cefotetan has been researched along with Bacteroides Infections in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 6 (54.55) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishino, T; Saito, M; Saito, T; Shibata, K; Tanino, T; Yano, K | 1 |
Brook, I | 4 |
Adams, RB; May, AK; Pruett, TL; Rosenlof, LK; Sawyer, RG | 1 |
Alfonso, B; Ehrenkranz, NJ | 1 |
Farmer, SG; Grossmeyer, TJ | 1 |
Encarnacion, C; Mehta, RN; Nehra, A | 1 |
Marradi, C; Nardone, A; Nespoli, A; Padalino, P | 1 |
Citron, DM; Goldstein, EJ | 1 |
11 other study(ies) available for cefotetan and Bacteroides Infections
Article | Year |
---|---|
Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
Topics: Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefazolin; Cefmetazole; Cefotetan; Cephamycins; Escherichia coli Infections; Fusobacterium Infections; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred Strains; Serratia marcescens | 1984 |
Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Cephamycins; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Penicillins; Peritoneal Diseases; Sulbactam | 1995 |
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Topics: Abscess; Amphotericin B; Animals; Bacteroides fragilis; Bacteroides Infections; Candida albicans; Candidiasis; Cefotetan; Cefoxitin; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred BALB C; Peritoneal Diseases; Peritonitis; Survival Rate | 1995 |
Increased resistance to cefoxitin and cefotetan among Bacteroides fragilis isolates from abdominal sources in patients undergoing surgery.
Topics: Abdomen; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Humans; Surgical Wound Infection | 1993 |
Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
Topics: Bacteria, Anaerobic; Bacterial Infections; Bacteroides; Bacteroides Infections; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1993 |
Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Drug Evaluation, Preclinical; Escherichia coli Infections; Male; Mice | 1993 |
Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 1993 |
Bacteroides fragilis arthritis in a patient with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Arthritis, Infectious; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Clavulanic Acid; Diagnosis, Differential; Humans; Male; Metronidazole; Ticarcillin; Treatment Outcome | 2001 |
Cefotetan versus clindamycin/tobramycin association in mixed aero-anaerobic peritonitis in rats.
Topics: Acute-Phase Proteins; Animals; Bacteroides Infections; Cefotetan; Clindamycin; Drug Therapy, Combination; Escherichia coli Infections; Liver; Male; Muscles; Peritonitis; Proteins; Rats; Rats, Inbred Strains; Tobramycin | 1987 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
Topics: Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Ceftizoxime; Humans; Microbial Sensitivity Tests; Periodicity | 1988 |